| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3607e42c88313be019fcdc94a664e7f4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-168 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 |
| filingDate |
2016-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b693449616f84fb7332df893ee7ad4ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17f4a41393073e54930874f1b1de46c6 |
| publicationDate |
2017-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201710283-A |
| titleOfInvention |
Inhibition of osteoblastogenesis |
| abstract |
The present invention is generally directed to new medical uses of fungal immunomodulatory proteins. More specifically, the present invention relates to the use of a fungal immunomodulatory protein and a composition containing a fungal immunomodulatory protein to inhibit osteoclastogenesis, inhibit bone resorption, and prevent and treat bone loss-related diseases. |
| priorityDate |
2015-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |